IBB
- iShares Biotechnology ETFInformations clés
| Date la plus ancienne | 2001-02-12 |
Informations sur l'ETF
| Émetteur du fonds | BlackRock |
| Indice | ICE Biotechnology Index |
| Frais de gestion | 0.45% |
| Nombre de positions | 211 |
| Date de création | 2001-02-05 |
| Classe d'actifs | Equity |
| Devise | USD |
| Cotation | US-listed |
| Secteur | Healthcare |
| Style d'investissement | Growth |
| Sans effet de levier | Non-leveraged |
À propos de IBB
The iShares Biotechnology ETF provides exposure to the biotechnology sub-sector of the health care industry, investing in a diversified portfolio of over 200 stocks. The fund focuses on U.S. biotechnology companies, with a smaller allocation to international firms, and employs a tiered weighting scheme. It offers a multi-cap approach, investing in large, mid, and small-cap stocks, making it a comprehensive option for investors seeking biotech exposure.